Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of tagatose on glycemic response and gut microbiota in healthy adults, with relevance to glucose intolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tagatose (tagatose)

Snippet

Sponsor: PepsiCo Global R&D | Conditions: Glucose Intolerance, Microbial Colonization | NA | Status: COMPLETED